News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,302 Results
Type
Article (50007)
Company Profile (280)
Press Release (689015)
Multimedia
Podcasts (64)
Webinars (12)
Section
Business (212822)
Career Advice (2106)
Deals (36648)
Drug Delivery (104)
Drug Development (83665)
Employer Resources (173)
FDA (17026)
Job Trends (15744)
News (360029)
Policy (34742)
Tag
Academia (2791)
Accelerated approval (5)
Adcomms (23)
Allergies (89)
Alliances (51762)
ALS (98)
Alzheimer's disease (1445)
Antibody-drug conjugate (ADC) (137)
Approvals (17021)
Artificial intelligence (285)
Autoimmune disease (23)
Automation (16)
Bankruptcy (373)
Best Places to Work (12103)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (193)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (302)
Cancer (2366)
Cardiovascular disease (191)
Career advice (1769)
Career pathing (31)
CAR-T (156)
Cell therapy (440)
Cervical cancer (22)
Clinical research (68012)
Collaboration (884)
Company closure (2)
Compensation (560)
Complete response letters (21)
COVID-19 (2722)
CRISPR (43)
C-suite (263)
Cystic fibrosis (103)
Data (2326)
Decentralized trials (2)
Denatured (29)
Depression (51)
Diabetes (282)
Diagnostics (6618)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (109)
Drug shortages (28)
Duchenne muscular dystrophy (98)
Earnings (89256)
Editorial (42)
Employer branding (21)
Employer resources (147)
Events (117806)
Executive appointments (762)
FDA (18437)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (788)
Gene editing (114)
Generative AI (25)
Gene therapy (317)
GLP-1 (769)
Government (4704)
Grass and pollen (4)
Guidances (150)
Healthcare (19928)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (125)
Indications (30)
Infectious disease (2873)
Inflammatory bowel disease (150)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (97)
Interviews (321)
IPO (16926)
IRA (41)
Job creations (4060)
Job search strategy (1507)
Kidney cancer (10)
Labor market (43)
Layoffs (493)
Leadership (18)
Legal (8474)
Liver cancer (79)
Lung cancer (333)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (330)
MASH (76)
Medical device (14422)
Medtech (14427)
Mergers & acquisitions (20299)
Metabolic disorders (739)
Multiple sclerosis (84)
NASH (16)
Neurodegenerative disease (102)
Neuropsychiatric disorders (31)
Neuroscience (2020)
NextGen: Class of 2025 (6929)
Non-profit (4748)
Now hiring (40)
Obesity (394)
Opinion (219)
Ovarian cancer (81)
Pain (96)
Pancreatic cancer (89)
Parkinson's disease (155)
Partnered (21)
Patents (244)
Patient recruitment (118)
Peanut (48)
People (60398)
Pharmaceutical (68)
Pharmacy benefit managers (20)
Phase I (21159)
Phase II (29885)
Phase III (22329)
Pipeline (1357)
Policy (150)
Postmarket research (2741)
Preclinical (9046)
Press Release (67)
Prostate cancer (110)
Psychedelics (32)
Radiopharmaceuticals (256)
Rare diseases (396)
Real estate (6326)
Recruiting (65)
Regulatory (23777)
Reports (47)
Research institute (2488)
Resumes & cover letters (360)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (77)
Series A (133)
Series B (90)
Service/supplier (13)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (153)
Sponsored (31)
Startups (3840)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (48)
The Weekly (33)
Vaccines (740)
Venture capitalists (43)
Weight loss (264)
Women's health (39)
Worklife (16)
Date
Today (162)
Last 7 days (941)
Last 30 days (3136)
Last 365 days (33283)
2025 (11983)
2024 (36170)
2023 (41215)
2022 (52444)
2021 (57178)
2020 (55999)
2019 (48907)
2018 (37016)
2017 (33858)
2016 (33678)
2015 (39737)
2014 (33411)
2013 (28673)
2012 (30952)
2011 (31656)
2010 (30025)
Location
Africa (796)
Alabama (55)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (41127)
Australia (6782)
California (6448)
Canada (2076)
China (553)
Colorado (283)
Connecticut (298)
Delaware (160)
Europe (89624)
Florida (955)
Georgia (220)
Idaho (62)
Illinois (588)
India (26)
Indiana (325)
Iowa (11)
Japan (174)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (959)
Massachusetts (4847)
Michigan (231)
Minnesota (417)
Mississippi (2)
Missouri (89)
Montana (27)
Nebraska (25)
Nevada (69)
New Hampshire (68)
New Jersey (1816)
New Mexico (29)
New York (1820)
North Carolina (1060)
North Dakota (8)
Northern California (2826)
Ohio (211)
Oklahoma (15)
Oregon (35)
Pennsylvania (1430)
Puerto Rico (13)
Rhode Island (35)
South America (1190)
South Carolina (26)
South Dakota (1)
Southern California (2429)
Tennessee (107)
Texas (960)
United States (24449)
Utah (193)
Virginia (156)
Washington D.C. (68)
Washington State (584)
West Virginia (3)
Wisconsin (60)
739,302 Results for "seno medical instruments inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Alex Hamlow Joins Seno Medical as Chief Revenue Officer
Alex Hamlow has joined Seno Medical Instruments, Inc. as Chief Revenue Officer. Seno Medical is the leader in improving the process of diagnosing breast cancer and the pioneer of the Imagio® Breast Imaging System with opto-acoustic/ultrasound (OA/US) imaging technology.
September 22, 2023
·
3 min read
Lone Star Bio
Study Finds Opto-Acoustic Imaging During Neoadjuvant Therapy Correlates to Pathologic ResponseStudy evaluates feasibility of leveraging Seno’s Imagio® System to detect response earlier during breast cancer therapy.
A limited feasibility study presented at this year’s San Antonio Breast Cancer Symposium (SABCS) found that Seno Medical’s Imagio® Breast Imaging System using opto-acoustic/ultrasound (OA/US) shows promise in detecting vessel and oxygenation changes preceding tumor volume decrease in patients who are in a trajectory to achieve a tumor pathologic complete response (pCR).
December 8, 2023
·
4 min read
Lone Star Bio
Seno Medical Inks Exclusive Agreement with Genetik, Inc. as Distributor for Imagio® Breast Imaging System in Southeast Asia
Seno Medical has entered into an exclusive distributor agreement with Genetik, Inc., to market, sell and service the company’s groundbreaking Imagio® Opto-Acoustic/Ultrasound Breast Imaging System.
January 13, 2023
·
3 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
Press Releases
Turbett Surgical Receives FDA 510(k) Clearance for Enhanced Instrument Pod Portfolio
April 11, 2025
·
2 min read
Press Releases
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
April 29, 2025
·
2 min read
Press Releases
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
March 25, 2025
·
3 min read
Press Releases
Transverse Medical Inc. Announces Completion of Series B2 Capital Raise
April 29, 2025
·
2 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
April 30, 2025
·
1 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
1 of 73,931
Next
